Literature DB >> 7840512

Relationship between area of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer.

M Ikeguchi1, A Oka, S Tsujitani, M Maeta, N Kaibara.   

Abstract

This study, we evaluated the relationship between the macroscopic area of serosal invasion by gastric carcinoma and the incidence of intraperitoneal free cancer cells which were detected by lavage of the Douglas cavity. Between 1976 and 1989, 362 patients with advanced gastric cancer (t3, t4) were gastrectomized and intraperitoneal free cancer cells were recognized in 119 patients (32.9%). Only 17.3% of patients with an area of serosal invasion of less than 10 cm2 had free cancer cells in their peritoneal cavities, however, 68.5% of patients with an area of serosal invasion greater than 20 cm2 had free cancer cells. Even, if curative surgery was performed for patients with free cancer cells, their five-year survival rate was very poor. The five-year survival rate of patients with curatively operated gastric cancer without free cancer cells was 49.3%, however that of patients with free cancer cells was significantly lower (15.4%, P < 0.01). Even when we are not able to receive the cytologic diagnosis for intraperitoneal free cancer cells during the operation, patients with macroscopic areas of serosal invasion greater than 20 cm2 may have free cancer cells in a very high percentage. They should be treated with effective adjuvant chemotherapy the soon after the operation to prevent peritoneal metastatic recurrence and to prolong survival.

Entities:  

Mesh:

Year:  1994        PMID: 7840512

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  36 in total

1.  Clinical outcomes according to primary treatment in gastric cancer patients with peritoneal seeding.

Authors:  Jung Min Bae; Kyoung Joon Yeo; Se Won Kim; Sang Woon Kim; Sun Kyo Song
Journal:  J Gastric Cancer       Date:  2011-09-29       Impact factor: 3.720

2.  Importance of positive peritoneal lavage cytology findings in the stage grouping of gastric cancer.

Authors:  T Suzuki; T Ochiai; H Hayashi; K Nakajima; A Yasumoto; E Hishikawa; H Shimada; F Horiuchi; S Ohki; K Isono
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

3.  Prognostic significance of peritoneal lavage cytology in gastric cancer in Singapore.

Authors:  Esther W L Chuwa; Lay-Wai Khin; Weng-Hoong Chan; Hock-Soo Ong; Wai-Keong Wong
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

4.  Usefulness of the neutrophil/lymphocyte ratio measured preoperatively as a predictor of peritoneal metastasis in patients with advanced gastric cancer.

Authors:  Yusuke Nakayama; Naoto Gotohda; Hidehito Shibasaki; Shogo Nomura; Takahiro Kinoshita; Ryuichi Hayashi
Journal:  Surg Today       Date:  2014-05-16       Impact factor: 2.549

5.  The result of conversion surgery in gastric cancer patients with peritoneal seeding.

Authors:  Se Won Kim
Journal:  J Gastric Cancer       Date:  2014-12-26       Impact factor: 3.720

Review 6.  Evolution of management in peritoneal surface malignancies.

Authors:  Emel Canbay; Bahar Canbay Torun; Ege Sinan Torun; Yutaka Yonemura
Journal:  Ulus Cerrahi Derg       Date:  2015-09-01

7.  The prognostic significance of macroscopic serosal change in subserosal invasion (stage T3) gastric cancer.

Authors:  B Zhao; D Mei; J Zhang; S Zou; Hn Lu; H Xu; B Huang
Journal:  Ann R Coll Surg Engl       Date:  2019-01-03       Impact factor: 1.891

8.  A foreign body granuloma after gastric perforation mimicking peritoneal dissemination of gastric cancer: report of a case.

Authors:  Hirofumi Akita; Yasunori Watanabe; Hideyuki Ishida; Kazunori Nakaguchi; Tsuyoshi Okino; Toshiyuki Kabuto
Journal:  Surg Today       Date:  2009-09-24       Impact factor: 2.549

9.  Hyperthermic intraperitoneal chemotherapy (HIPEC) and neoadjuvant chemotherapy as prophylaxis of peritoneal carcinosis from advanced gastric cancer-effects on overall and disease free survival.

Authors:  Federico Coccolini; Andrea Celotti; Marco Ceresoli; Giulia Montori; Michele Marini; Fausto Catena; Luca Ansaloni
Journal:  J Gastrointest Oncol       Date:  2016-08

Review 10.  [Resection of advanced esophagogastric adenocarcinoma : Extended indications].

Authors:  S P Mönig; L M Schiffmann
Journal:  Chirurg       Date:  2016-05       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.